Ratings by Guggenheim (Michael Sch)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/17/2026 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2026 | CytomX Therapeutics | CTMX | New Coverage | Buy (N/A) |
5.39 (3.40) |
-36.92% | Details |
